Rab,
Revenue was down by 3% - for the 1/2 year only. That ain't too bad? They even gave a reason change in debt purchasing model ("principally"). That sounded fair enough to me.
Profit was up by 80%, I thought that sounded fine. I still think it sounds fine.
- Forums
- ASX - By Stock
- what is going on
RPC
repcol limited
Rab,Revenue was down by 3% - for the 1/2 year only. That ain't...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online